Ryan Specialty moves ahead with IPO of 57m shares
US-based Ryan Specialty Group has filed for its planned initial public offering (IPO), which would generate net proceeds of up to $1.42 billion.
Ryan Specialty is offering 56,918,278 shares of its Class A common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (SEC).
The IPO price is expected to be between $22.00 and $25.00 per share. Ryan Specialty intends to grant the underwriters the right to purchase up to an additional 8,537,742 shares of its Class A common stock.
The company said it intends to use the net proceeds received from this offering to acquire newly issued LLC units of Ryan Specialty Group; and the equity of an entity through which an affiliate of Onex Corporation holds its preferred unit interest in Ryan Specialty Group.
It also seeks to acquire outstanding LLC units of Ryan Specialty Group from certain existing holders of LLC units at a purchase price per LLC unit equal to the initial public offering price per share of Class A common stock in this offering, less underwriting fees and commissions.
Upon completion of the proposed initial public offering, the Patrick Ryan-led group will be the sole managing member of Ryan Specialty Group and will exclusively operate and control all of its business and affairs.
The company has applied to list its Class A common stock on the New York Stock Exchange under the symbol 'RYAN'.
JP Morgan, Barclays, Goldman Sachs & Co. and Wells Fargo Securities are acting as lead book-running managers, and UBS Investment Bank, William Blair, RBC Capital Markets, BMO Capital Markets, and Keefe, Bruyette & Woods, A Stifel Company, are acting as book-running managers for the proposed offering.
Dowling & Partners Securities, Nomura, Capital One Securities, CIBC Capital Markets, Loop Capital Markets, PNC Capital Markets, Ramirez & Co., and Siebert Williams Shank are acting as co-managers for the proposed offering.
Did you get value from this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Elliot Field at efield@newtonmedia.co.uk or Adrian Tapping at atapping@newtonmedia.co.uk
Editor's picks
Editor's picks
More articles
Copyright © intelligentinsurer.com 2024 | Headless Content Management with Blaze